AU2003283500A1 - 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors - Google Patents
1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptorsInfo
- Publication number
- AU2003283500A1 AU2003283500A1 AU2003283500A AU2003283500A AU2003283500A1 AU 2003283500 A1 AU2003283500 A1 AU 2003283500A1 AU 2003283500 A AU2003283500 A AU 2003283500A AU 2003283500 A AU2003283500 A AU 2003283500A AU 2003283500 A1 AU2003283500 A1 AU 2003283500A1
- Authority
- AU
- Australia
- Prior art keywords
- nonanecarboxamide
- diazabicyclo
- malfunction
- derivatives
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 title 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
- 230000007257 malfunction Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0212500A FR2845388B1 (fr) | 2002-10-08 | 2002-10-08 | Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique |
| FR02/12500 | 2002-10-08 | ||
| PCT/FR2003/002929 WO2004033456A2 (fr) | 2002-10-08 | 2003-10-06 | Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique ayant trait au dysfonctionnement des recepteurs nicotiniques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003283500A1 true AU2003283500A1 (en) | 2004-05-04 |
| AU2003283500A8 AU2003283500A8 (en) | 2004-05-04 |
Family
ID=32011522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003283500A Abandoned AU2003283500A1 (en) | 2002-10-08 | 2003-10-06 | 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1575960B1 (https=) |
| JP (1) | JP4537853B2 (https=) |
| AR (1) | AR041527A1 (https=) |
| AT (1) | ATE425980T1 (https=) |
| AU (1) | AU2003283500A1 (https=) |
| DE (1) | DE60326757D1 (https=) |
| FR (1) | FR2845388B1 (https=) |
| TW (1) | TWI320413B (https=) |
| WO (1) | WO2004033456A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05003317A (es) | 2002-09-25 | 2005-07-05 | Memory Pharm Corp | Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos. |
| DE602004010299T2 (de) | 2003-12-22 | 2008-09-18 | Memory Pharmaceuticals Corp. | Indole, 1h-indazole, 1,2-benzisoxazole und 1,2-benzisothiazole und deren herstellung und anwendungen |
| FR2865208B1 (fr) * | 2004-01-16 | 2009-01-16 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique |
| NZ550534A (en) | 2004-03-25 | 2009-07-31 | Memory Pharm Corp | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| WO2006001894A1 (en) * | 2004-04-22 | 2006-01-05 | Memory Pharmaceutical Corporation | Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| JP2007538011A (ja) * | 2004-05-07 | 2007-12-27 | メモリー・ファーマシューティカルズ・コーポレイション | １ｈ−インダゾール、ベンゾチアゾール、１，２−ベンゾイソキサゾール、１，２−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用 |
| CA2569887A1 (en) | 2004-06-09 | 2005-12-22 | Glaxo Group Limited | Pyrrolopyridine derivatives |
| RU2418797C2 (ru) | 2004-12-22 | 2011-05-20 | Мемори Фармасьютиклз Корпорейшн | Лиганды никотинового рецептора альфа-7, их получение и применение |
| WO2007056582A1 (en) * | 2005-11-09 | 2007-05-18 | Memory Pharmaceuticals Corporation | 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| EP1842541A1 (en) * | 2006-03-29 | 2007-10-10 | G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg | Plant components and extracts and uses thereof |
| CN101910170A (zh) * | 2007-10-22 | 2010-12-08 | 记忆药物公司 | 用于治疗疾病的烟碱性乙酰胆碱受体的(1,4-二氮杂双环[3.2.2]壬-6-烯-4-基)-杂环基-甲酮配体 |
| WO2022125377A1 (en) * | 2020-12-08 | 2022-06-16 | Disarm Therapeutics, Inc. | Benzopyrazole inhibitors of sarm1 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
| FR2786770B1 (fr) * | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
| FR2804430B1 (fr) * | 2000-01-28 | 2002-03-22 | Sanofi Synthelabo | Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique |
| FR2809730B1 (fr) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique |
| US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
-
2002
- 2002-10-08 FR FR0212500A patent/FR2845388B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-06 JP JP2004542551A patent/JP4537853B2/ja not_active Expired - Fee Related
- 2003-10-06 EP EP03775474A patent/EP1575960B1/fr not_active Expired - Lifetime
- 2003-10-06 AT AT03775474T patent/ATE425980T1/de not_active IP Right Cessation
- 2003-10-06 DE DE60326757T patent/DE60326757D1/de not_active Expired - Lifetime
- 2003-10-06 AR ARP030103628A patent/AR041527A1/es unknown
- 2003-10-06 AU AU2003283500A patent/AU2003283500A1/en not_active Abandoned
- 2003-10-06 WO PCT/FR2003/002929 patent/WO2004033456A2/fr not_active Ceased
- 2003-10-07 TW TW092127821A patent/TWI320413B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200505926A (en) | 2005-02-16 |
| EP1575960B1 (fr) | 2009-03-18 |
| WO2004033456A3 (fr) | 2004-05-27 |
| FR2845388A1 (fr) | 2004-04-09 |
| FR2845388B1 (fr) | 2004-11-12 |
| AR041527A1 (es) | 2005-05-18 |
| JP4537853B2 (ja) | 2010-09-08 |
| JP2006506356A (ja) | 2006-02-23 |
| ATE425980T1 (de) | 2009-04-15 |
| TWI320413B (en) | 2010-02-11 |
| AU2003283500A8 (en) | 2004-05-04 |
| WO2004033456A2 (fr) | 2004-04-22 |
| DE60326757D1 (de) | 2009-04-30 |
| EP1575960A2 (fr) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002340999A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| HRP20040027A2 (en) | 1-phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| AU2003264448A1 (en) | Novel 6-substituted uracil derivative and therapeutic agent for allergic disease | |
| AU2003246810A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
| AU2003289641A1 (en) | The novel coumarin-amide derivatives and its preparation, said drug composition and its use | |
| AU2001282267A1 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
| AU2003255645A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
| IL172733A0 (en) | Diphenylpyridine derivatives, preparation and therapeutic application thereof | |
| AU2003224747A1 (en) | Technetium-labeled rotenone derivatives, and methods of use thereof | |
| AU2003269018A1 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
| AU2003283500A1 (en) | 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors | |
| AU2001264044A1 (en) | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof | |
| AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
| TWI318974B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic use | |
| AU2003260566A1 (en) | Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine | |
| IL162524A0 (en) | Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application | |
| PL374858A1 (en) | Novel arylimidazole derivatives, preparation and therapeutic uses thereof | |
| PL375309A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
| AU2002229870A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
| AU2003240052A1 (en) | Il-11 derivatives and therapeutic uses thereof | |
| PL365342A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
| AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof | |
| AU2003264474A1 (en) | Novel uracil derivatives and medicinal use thereof | |
| AU2001237518A1 (en) | Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application | |
| AU2002237228A1 (en) | Regulation of human adenylate cyclase, type vii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |